BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 29756515)

  • 1. Effects of polaprezinc on gastric mucosal damage and neurotransmitters in a rat model of chemotherapy-induced vomiting.
    Liu ZY; Xie WB; Ru Li M; Teng N; Liang X; Zhang ZQ
    J Int Med Res; 2018 Jun; 46(6):2436-2444. PubMed ID: 29756515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of polaprezinc on gastric mucosal protection in rats with ethanol-induced gastric mucosal damage: comparison study with rebamipide.
    Choi HS; Lim JY; Chun HJ; Lee M; Kim ES; Keum B; Seo YS; Jeen YT; Um SH; Lee HS; Kim CD; Ryu HS; Sul D
    Life Sci; 2013 Jul; 93(2-3):69-77. PubMed ID: 23743168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Residence time of polaprezinc (zinc L-carnosine complex) in the rat stomach and adhesiveness to ulcerous sites.
    Furuta S; Toyama S; Miwa M; Itabashi T; Sano H; Yoneta T
    Jpn J Pharmacol; 1995 Apr; 67(4):271-8. PubMed ID: 7650862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zinc L-carnosine protects colonic mucosal injury through induction of heat shock protein 72 and suppression of NF-kappaB activation.
    Odashima M; Otaka M; Jin M; Wada I; Horikawa Y; Matsuhashi T; Ohba R; Hatakeyama N; Oyake J; Watanabe S
    Life Sci; 2006 Nov; 79(24):2245-50. PubMed ID: 16949620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ginger extract and polaprezinc exert gastroprotective actions by anti-oxidant and growth factor modulating effects in rats.
    Ko JK; Leung CC
    J Gastroenterol Hepatol; 2010 Dec; 25(12):1861-8. PubMed ID: 21091998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irritant action of monochloramine in rat stomachs: effects of zinc L-carnosine (polaprezinc).
    Nishiwaki H; Kato S; Takeuchi K
    Gen Pharmacol; 1997 Nov; 29(5):713-8. PubMed ID: 9347315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polaprezinc (Zinc L-carnosine) is a potent inducer of anti-oxidative stress enzyme, heme oxygenase (HO)-1 - a new mechanism of gastric mucosal protection.
    Ueda K; Ueyama T; Oka M; Ito T; Tsuruo Y; Ichinose M
    J Pharmacol Sci; 2009 Jul; 110(3):285-94. PubMed ID: 19542683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection by polaprezinc, an anti-ulcer drug, against indomethacin-induced apoptosis in rat gastric mucosal cells.
    Fuji Y; Matsura T; Kai M; Kawasaki H; Yamada K
    Jpn J Pharmacol; 2000 Sep; 84(1):63-70. PubMed ID: 11043455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactive oxygen species-quenching and anti-apoptotic effect of polaprezinc on indomethacin-induced small intestinal epithelial cell injury.
    Omatsu T; Naito Y; Handa O; Mizushima K; Hayashi N; Qin Y; Harusato A; Hirata I; Kishimoto E; Okada H; Uchiyama K; Ishikawa T; Takagi T; Yagi N; Kokura S; Ichikawa H; Yoshikawa T
    J Gastroenterol; 2010 Jul; 45(7):692-702. PubMed ID: 20174833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of polaprezinc for acute radiation proctitis in a rat model.
    Doi H; Kamikonya N; Takada Y; Fujiwara M; Tsuboi K; Inoue H; Tanooka M; Nakamura T; Shikata T; Tsujimura T; Hirota S
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):877-84. PubMed ID: 21377290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polaprezinc attenuates cyclophosphamide-induced cystitis and related bladder pain in mice.
    Murakami-Nakayama M; Tsubota M; Hiruma S; Sekiguchi F; Matsuyama K; Kimura T; Moriyama M; Kawabata A
    J Pharmacol Sci; 2015 Feb; 127(2):223-8. PubMed ID: 25727961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polaprezinc down-regulates proinflammatory cytokine-induced nuclear factor-kappaB activiation and interleukin-8 expression in gastric epithelial cells.
    Shimada T; Watanabe N; Ohtsuka Y; Endoh M; Kojima K; Hiraishi H; Terano A
    J Pharmacol Exp Ther; 1999 Oct; 291(1):345-52. PubMed ID: 10490923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo effects of s-pantoprazole, polaprenzinc, and probiotic blend on chronic small intestinal injury induced by indomethacin.
    Byun SJ; Lim TJ; Lim YJ; Seo JG; Chung MJ
    Benef Microbes; 2016 Nov; 7(5):731-737. PubMed ID: 27824272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal ulcerogenic action of monochloramine in rat stomachs: effects of polaprezinc and sucralfate.
    Kato S; Nishiwaki H; Konaka A; Takeuchi K
    Dig Dis Sci; 1997 Oct; 42(10):2156-63. PubMed ID: 9365151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral Administration of Polaprezinc Attenuates Fluorouracil-induced Intestinal Mucositis in a Mouse Model.
    Liu Z; Xie W; Li M; Teng N; Liang X; Zhang Z; Yang Z; Wang X
    Basic Clin Pharmacol Toxicol; 2017 Dec; 121(6):480-486. PubMed ID: 28667794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polaprezinc protects gastric mucosal cells from noxious agents through antioxidant properties in vitro.
    Hiraishi H; Sasai T; Oinuma T; Shimada T; Sugaya H; Terano A
    Aliment Pharmacol Ther; 1999 Feb; 13(2):261-9. PubMed ID: 10102958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polaprezinc, a gastroprotective agent: attenuation of monochloramine-evoked gastric DNA fragmentation.
    Suzuki H; Mori M; Seto K; Nagahashi S; Kawaguchi C; Morita H; Suzuki M; Miura S; Yoneta T; Ishii H
    J Gastroenterol; 1999; 34 Suppl 11():43-6. PubMed ID: 10616765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ulcerogenic and healing impairing actions of monochloramine in rat stomachs: effects of zinc L-carnosine, polaprezinc.
    Nishiwaki H; Kato S; Sugamoto S; Umeda M; Morita H; Yoneta T; Takeuchi K
    J Physiol Pharmacol; 1999 Jun; 50(2):183-95. PubMed ID: 10424716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcineurin inhibition by polaprezinc in rats with experimentally-induced colitis.
    Zhang Y; Okamura S; Kudo T; Masuo T; Mori M
    Life Sci; 2011 Feb; 88(9-10):432-9. PubMed ID: 21219912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of polaprezinc on lipid peroxidation, neutrophil accumulation, and TNF-alpha expression in rats with aspirin-induced gastric mucosal injury.
    Naito Y; Yoshikawa T; Yagi N; Matsuyama K; Yoshida N; Seto K; Yoneta T
    Dig Dis Sci; 2001 Apr; 46(4):845-51. PubMed ID: 11330422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.